Proprietary portfolio

We develop superior therapeutics that are clinically derisked and address unmet patient need in high value markets including diabetes and other cardiometabolic diseases, based on our Arestat® technology platform

OUR PORTFOLIO

Partnering

We partner with leading pharmaceutical and medtech companies to develop superior therapeutic profiles, leveraging our innovative and proprietary formulation and drug delivery technology

PARTNERING

Validated technology

Our development expertise is underpinned by our world-leading Arestat® technology platform, protected by a robust intellectual property portfolio

OUR TECHNOLOGY

Latest News

  • 28th April 2026

    BioSpace podcast – The next era of diabetes management

    CLICK HERE
  • 9th March 2026

    Arecor to present at Oppenheimer Annual Healthcare MedTech & Services Conference (16 March 2026)

    ↓ DOWNLOAD PDF
  • 23rd February 2026

    Arecor talks to Biotech TV

    CLICK HERE